Spasticity — Patent Landscape
3
Approved drugs
23
Active US patents
68/100
Avg vulnerability
—
Annual revenue covered
Originators in Spasticity
Cliff calendar — next 15 years
15
29
6
32
1
39
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Valium
diazepam
|
Generic (originally Roche) | 21 | 67 | — | 2029-03-27 |
|
Skelaxin
METAXALONE
|
Pfizer | 1 | 63 | — | 2039-07-29 |
|
Robaxin
METHOCARBAMOL
|
Hikma | 1 | 75 | — | 2044-10-09 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12337061 | Valium | method of use | 75 | 2032-06-13 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 12324852 | Valium | method of use | 75 | 2032-10-16 |
| 12390439 | Robaxin | method of use | 75 | 2044-10-09 |
| 12268664 | Valium | formulation | 68 | 2029-03-27 |
| 12521400 | Valium | formulation | 68 | 2029-03-27 |
| 12521400 | Valium | formulation | 68 | 2029-03-27 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 11918559 | Skelaxin | formulation | 55 | 2039-07-29 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 8895546 | Valium | formulation | 55 | 2029-03-27 |
| 11793786 | Valium | formulation | 63 | 2029-03-27 |
| 11793786 | Valium | formulation | 63 | 2029-03-27 |
| 11793786 | Valium | formulation | 63 | 2029-03-27 |
| 11241414 | Valium | formulation | 63 | 2029-03-27 |
| 11241414 | Valium | formulation | 63 | 2029-03-27 |
| 11241414 | Valium | formulation | 63 | 2029-03-27 |
Related
- Spasticity — full disease profile
- AI Patent Landscape Report — type "spasticity" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner